STOCK TITAN

Tandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Tandem Diabetes Care to release Q3 2023 results on November 1, 2023
Positive
  • Tandem Diabetes Care plans to release its Q3 2023 results after the financial markets close on November 1, 2023.
Negative
  • None.

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2023 results after the financial markets close on Wednesday, November 1, 2023. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third quarter 2023 financial and operating results.

A live webcast of the call will be available on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section. To access the call by phone, please use this link (https://register.vevent.com/register/BIef8a824a5ebe4f3fbec7ba819e215d96) and you will be provided with dial-in details, including a personal pin.

An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience. The Company’s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. For more information, visit tandemdiabetes.com.

Tandem Diabetes Care and Control-IQ are trademarks registered in the U.S. and/or other countries and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2 and #TandemDiabetes.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.

Media Contact:

858-255-6388

media@tandemdiabetes.com

Investor Contact:

858-366-6900

IR@tandemdiabetes.com

Source: Tandem Diabetes Care, Inc.

FAQ

When will Tandem Diabetes Care release its Q3 2023 results?

Tandem Diabetes Care will release its Q3 2023 results on November 1, 2023.

What time will the conference call and webcast be held?

The conference call and webcast will be held at 4:30 pm Eastern Time (1:30 pm Pacific Time).

Where can I access the live webcast of the call?

You can access the live webcast on Tandem Diabetes Care's Investor Center website in the 'Events & Presentations' section.

Will there be an archive of the webcast available?

Yes, an archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care's Investor Center website.

Tandem Diabetes Care, Inc.

NASDAQ:TNDM

TNDM Rankings

TNDM Latest News

TNDM Stock Data

2.02B
65.14M
0.75%
114.24%
12.78%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
San Diego